JNJ

FDA Is Restricting This Johnson & Johnson Drug
Wall St. Cheat Sheet
Mon, 07/29/13 - 10:36 am
antifungals
FDA
JNJ
Nizoral
FDA limits use of J&J's Nizoral antifungal drug on safety concerns
Reuters
Fri, 07/26/13 - 11:25 am
FDA
JNJ
Nizoral
antifungals
Breakthrough Status May Spur J&J Drug to Market Early
Bloomberg
Thu, 07/25/13 - 10:42 am
JNJ
breakthrough therapies
ibrutinib
Pharmacyclics
chronic lymphocytic leukemia
mantle cell lymphoma
Why Johnson & Johnson's Long-Term Tailwinds Remain Intact
Seeking Alpha
Wed, 07/24/13 - 10:18 am
JNJ
The Diabetes Pipeline With a Clog
Motley Fool
Mon, 07/22/13 - 06:02 pm
diabetes
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
JNJ
SGLT2 inhibitor
Forxiga
Invokana
empagliflozin
Innovations In HIV: Johnson & Johnson, Glaxo Vs. Gilead
Seeking Alpha
Mon, 07/22/13 - 10:26 am
HIV
Atripla
JNJ
Pfizer
GSK
Gilead
Dolutegravir
Edurant
China
TMC310911
Can This Pharmaceutical Power Stay Healthy?
Daily Finance
Sat, 07/20/13 - 11:51 am
JNJ
J&J Agrees to Pay $22.9 Million to Settle on Drug Recalls
Bloomberg
Thu, 07/18/13 - 09:09 am
JNJ
recalls
J&J Pays $23M To Settle Class Action Suit Over OTC Troubles
Pharmalot
Wed, 07/17/13 - 11:10 am
OTC
JNJ
J&J results beat expectations, as drugs, devices deliver
Reuters
Tue, 07/16/13 - 09:22 am
earnings
JNJ
Johnson & Johnson (JNJ) Earnings Projected to Increase
Forbes
Mon, 07/15/13 - 10:25 am
JNJ
earnings
This Week in Biotech
Motley Fool
Sun, 07/14/13 - 11:19 am
Pharmacyclics
JNJ
Alnylam
Inovio
Alexion
Roche
A Developing "Breakthrough" In Biotechnology that You Should Monitor
Motley Fool
Sat, 07/13/13 - 12:31 pm
Pharmacyclics
ibrutinib
blood cancer
JNJ
AbbVie
Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick
Forbes
Sat, 07/13/13 - 12:04 pm
JNJ
Johnson & Johnson Earnings Are on Deck
Motley Fool
Fri, 07/12/13 - 07:33 am
earnings
JNJ
Laywer Spars With FDA Over J&J Risperdal Court Documents
Pharmalot
Thu, 07/11/13 - 12:10 pm
FDA
JNJ
Risperdal
Astex Pharmaceuticals In Focus With Catalyst In The Near Term
Seeking Alpha
Thu, 07/11/13 - 11:15 am
Astex
AstraZeneca
Celgene
GSK
JNJ
Novartis
SGI-110
Dacogen
Will This Be the Breakthrough of All Breakthrough Therapy Drugs?
Motley Fool
Thu, 07/11/13 - 11:09 am
breakthrough therapies
ibrutinib
Pharmacyclics
JNJ
chronic lymphocytic leukemia
How Johnson & Johnson Revamped its Executive Pay Practices
Forbes
Wed, 07/10/13 - 01:31 pm
JNJ
executive pay
Pharmacyclics and Johnson & Johnson submit blood cancer drug ibrutinib to FDA for approval
Yahoo/AP
Wed, 07/10/13 - 11:05 am
JNJ
Pharmacyclics
ibrutinib
chronic lymphocytic leukemia

Pages